Literature DB >> 17700200

Association between cytomegalovirus infection and venous thromboembolism.

Zvi G Fridlender1, Mogher Khamaisi, Eran Leitersdorf.   

Abstract

It has been suggested that cytomegalovirus (CMV) infection may be associated with thrombosis in immunocompromised patients. In addition, an association between CMV infection and thrombotic events in immunocompetent hosts has been sporadically reported. We report on 1 immunocompromised and 8 immunocompetent adults who were admitted to a tertiary medical center and experienced a venous thromboembolic event during CMV infection. None reported previous thromboembolic events. All patients were diagnosed as suffering from acute CMV infection. Seven of the patients had vein thromboses. Significant additional thrombophilia was identified in 5 patients; 1 had 15.3 U/mL anti-cardiolipin IgM antibodies (elevated >7), 2 others were not evaluated for genetic procoagulant tendency. The exact nature of the procoagulant effect of CMV has not yet been clarified. Even though these mechanistic studies are incomplete, we suggest that from the clinical perspective, the presence of CMV infection should be considered a possible risk factor for thrombophilia, justifying a high index of suspicion for possible thrombotic events and subsequent decisions regarding prophylactic anticoagulation.

Entities:  

Mesh:

Year:  2007        PMID: 17700200     DOI: 10.1097/MAJ.0b013e31812f5ba5

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  7 in total

Review 1.  Acute cytomegalovirus infection in liver transplant recipients: An independent risk for venous thromboembolism.

Authors:  Raja Gr Edula; Kamran Qureshi; Hicham Khallafi
Journal:  World J Hepatol       Date:  2013-12-27

2.  Pulmonary embolism and portal vein thrombosis in an immunocompetent adolescent with acute cytomegalovirus hepatitis.

Authors:  Antonio Mendoza Ladd; Rakesh Goyal; Louis Rosainz; Peter Baiocco; Larry DiFabrizio
Journal:  J Thromb Thrombolysis       Date:  2008-12-31       Impact factor: 2.300

3.  Pulmonary Embolism in a Young Immunocompetent Adult Infected with Cytomegalovirus. Are Novel Oral Anticoagulants an Efficient Alternative?

Authors:  Ioannis Bountouris; Demetrios Moris; Diamantis I Tsilimigras; George Laoutaris; Georgia Kritikou; Viktoria-Varvara Palla; Georgios Karaolanis
Journal:  In Vivo       Date:  2017 Nov-Dec       Impact factor: 2.155

4.  Pulmonary embolism in an immunocompetent patient with acute cytomegalovirus colitis.

Authors:  Jen-Wei Chou; Ken-Sheng Cheng
Journal:  Intest Res       Date:  2016-04-27

Review 5.  Review: Viral infections and mechanisms of thrombosis and bleeding.

Authors:  M Goeijenbier; M van Wissen; C van de Weg; E Jong; V E A Gerdes; J C M Meijers; D P M Brandjes; E C M van Gorp
Journal:  J Med Virol       Date:  2012-10       Impact factor: 2.327

Review 6.  Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review.

Authors:  Manuela Ceccarelli; Emmanuele Venanzi Rullo; Giuseppe Nunnari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-18       Impact factor: 5.103

Review 7.  Hyperthrombotic Milieu in COVID-19 Patients.

Authors:  Mohamed Hassan Kamel; Wenqing Yin; Chris Zavaro; Jean M Francis; Vipul C Chitalia
Journal:  Cells       Date:  2020-10-31       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.